LAMA LABA Uncontrolled Asthma ICS – Monthly Prescribing Reference (registration)


Monthly Prescribing Reference (registration)

LAMA LABA Uncontrolled Asthma ICS
Monthly Prescribing Reference (registration)
Long-acting muscarinic antagonists (LAMA) have been shown to reduce exacerbations of chronic obstructive pulmonary disease (COPD) and are now being considered for patients with uncontrolled asthma as add-on treatment. A review in the Cochrane …

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.